Global Nuclear Medicine Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	177 Pages	TechNavio	July, 2024	INF19287057

Best Price Guarantee
Price	from $2,500
Length	177 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19287057

Global Nuclear Medicine Market 2023-2027

Technavio has been monitoring the nuclear medicine market and is forecast to grow by $8057.89 mn during 2022-2027, accelerating at a CAGR of 16.48% during the forecast period. Our report on the nuclear medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of SPECT/CT hybrid imaging systems, increased use of nuclear medicine for detecting diseases at an early stage, and growing cancer cases and rising investment in the oncology market.

Technavio's nuclear medicine market is segmented as below:

By Product
Radiotherapeutics
Equipment SPECT and PET
By Application
Oncology
Cardiology
Neurology
Others
By Geographical Landscape
North America
Asia
Europe
Rest of World (ROW)

This study identifies the minimal side effects of radiopharmaceuticals as compared with their potential benefits as one of the prime reasons driving the nuclear medicine market growth during the next few years. Also, growing research activities to widen the applications of hybrid imaging and the constant discovery and development of new radiopharmaceuticals will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the nuclear medicine market covers the following areas:

Nuclear medicine market sizing
Nuclear medicine market forecast
Nuclear medicine market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nuclear medicine market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Eckert and Ziegler AG, ECZACIBASI MONROL NUCLEAR PRODUCTS CO., GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Koninklijke Philips NV, Lantheus Holdings Inc., Mallinckrodt Plc, Medi-Radiopharma , Mirion Technologies Inc., Necsa, Novartis AG, Siemens Healthineers AG, Sirtex Medical Pty Ltd., Telix Pharmaceuticals Ltd., Tema Sinergie SpA, and TTG Imaging Solutions LLC. Also, the nuclear medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Nuclear Medicine Market 2018 - 2022; Historic Market Size - Data Table on Global Nuclear Medicine Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Radiotherapeutics - Market size and forecast 2023-2028; Chart on Radiotherapeutics - Market size and forecast 2023-2028 ($ million); Data Table on Radiotherapeutics - Market size and forecast 2023-2028 ($ million); Chart on Radiotherapeutics - Year-over-year growth 2023-2028 (%); Data Table on Radiotherapeutics - Year-over-year growth 2023-2028 (%); 6.4 Equipment (SPECT and PET) - Market size and forecast 2023-2028; Chart on Equipment (SPECT and PET) - Market size and forecast 2023-2028 ($ million); Data Table on Equipment (SPECT and PET) - Market size and forecast 2023-2028 ($ million); Chart on Equipment (SPECT and PET) - Year-over-year growth 2023-2028 (%); Data Table on Equipment (SPECT and PET) - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Oncology - Market size and forecast 2023-2028; Chart on Oncology - Market size and forecast 2023-2028 ($ million); Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Chart on Oncology - Year-over-year growth 2023-2028 (%); Data Table on Oncology - Year-over-year growth 2023-2028 (%); 7.4 Cardiology - Market size and forecast 2023-2028; Chart on Cardiology - Market size and forecast 2023-2028 ($ million); Data Table on Cardiology - Market size and forecast 2023-2028 ($ million); Chart on Cardiology - Year-over-year growth 2023-2028 (%); Data Table on Cardiology - Year-over-year growth 2023-2028 (%); 7.5 Neurology - Market size and forecast 2023-2028; Chart on Neurology - Market size and forecast 2023-2028 ($ million); Data Table on Neurology - Market size and forecast 2023-2028 ($ million); Chart on Neurology - Year-over-year growth 2023-2028 (%); Data Table on Neurology - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.5 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.4 Bracco Spa; Bracco Spa - Overview; Bracco Spa - Product / Service; Bracco Spa - Key offerings; 12.5 Cardinal Health Inc.; Cardinal Health Inc. - Overview; Cardinal Health Inc. - Business segments; Cardinal Health Inc. - Key news; Cardinal Health Inc. - Key offerings; Cardinal Health Inc. - Segment focus; 12.6 Eckert and Ziegler AG; Eckert and Ziegler AG - Overview; Eckert and Ziegler AG - Business segments; Eckert and Ziegler AG - Key news; Eckert and Ziegler AG - Key offerings; Eckert and Ziegler AG - Segment focus; 12.7 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.; ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview; ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service; ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings; 12.8 GE Healthcare Technologies Inc.; GE Healthcare Technologies Inc. - Overview; GE Healthcare Technologies Inc. - Business segments; GE Healthcare Technologies Inc. - Key news; GE Healthcare Technologies Inc. - Key offerings; GE Healthcare Technologies Inc. - Segment focus; 12.9 IBA Radiopharma Solutions; IBA Radiopharma Solutions - Overview; IBA Radiopharma Solutions - Business segments; IBA Radiopharma Solutions - Key news; IBA Radiopharma Solutions - Key offerings; IBA Radiopharma Solutions - Segment focus; 12.10 Jubilant Pharmova Ltd.; Jubilant Pharmova Ltd. - Overview; Jubilant Pharmova Ltd. - Business segments; Jubilant Pharmova Ltd. - Key news; Jubilant Pharmova Ltd. - Key offerings; Jubilant Pharmova Ltd. - Segment focus; 12.11 Koninklijke Philips N.V.; Koninklijke Philips N.V. - Overview; Koninklijke Philips N.V. - Business segments; Koninklijke Philips N.V. - Key news; Koninklijke Philips N.V. - Key offerings; Koninklijke Philips N.V. - Segment focus; 12.12 Mallinckrodt Plc; Mallinckrodt Plc - Overview; Mallinckrodt Plc - Business segments; Mallinckrodt Plc - Key news; Mallinckrodt Plc - Key offerings; Mallinckrodt Plc - Segment focus; 12.13 Medi-Radiopharma; Medi-Radiopharma - Overview; Medi-Radiopharma - Product / Service; Medi-Radiopharma - Key offerings; 12.14 Necsa; Necsa - Overview; Necsa - Product / Service; Necsa - Key offerings; 12.15 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.16 Siemens Healthineers AG; Siemens Healthineers AG - Overview; Siemens Healthineers AG - Business segments; Siemens Healthineers AG - Key news; Siemens Healthineers AG - Key offerings; Siemens Healthineers AG - Segment focus; 12.17 Sirtex Medical Pty Ltd.; Sirtex Medical Pty Ltd. - Overview; Sirtex Medical Pty Ltd. - Product / Service; Sirtex Medical Pty Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Nuclear Medicine Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Radiotherapeutics - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Radiotherapeutics - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Radiotherapeutics - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Radiotherapeutics - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Equipment (SPECT and PET) - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Equipment (SPECT and PET) - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Equipment (SPECT and PET) - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Product ($ million); Exhibits45: Data Table on Market opportunity by Product ($ million); Exhibits46: Chart on Application - Market share 2023-2028 (%); Exhibits47: Data Table on Application - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Application; Exhibits49: Data Table on Comparison by Application; Exhibits50: Chart on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Oncology - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Oncology - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Cardiology - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Cardiology - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Cardiology - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Neurology - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Neurology - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Neurology - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Neurology - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Application ($ million); Exhibits67: Data Table on Market opportunity by Application ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Bayer AG - Overview; Exhibits118: Bayer AG - Business segments; Exhibits119: Bayer AG - Key news; Exhibits120: Bayer AG - Key offerings; Exhibits121: Bayer AG - Segment focus; Exhibits122: Bracco Spa - Overview; Exhibits123: Bracco Spa - Product / Service; Exhibits124: Bracco Spa - Key offerings; Exhibits125: Cardinal Health Inc. - Overview; Exhibits126: Cardinal Health Inc. - Business segments; Exhibits127: Cardinal Health Inc. - Key news; Exhibits128: Cardinal Health Inc. - Key offerings; Exhibits129: Cardinal Health Inc. - Segment focus; Exhibits130: Eckert and Ziegler AG - Overview; Exhibits131: Eckert and Ziegler AG - Business segments; Exhibits132: Eckert and Ziegler AG - Key news; Exhibits133: Eckert and Ziegler AG - Key offerings; Exhibits134: Eckert and Ziegler AG - Segment focus; Exhibits135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview; Exhibits136: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service; Exhibits137: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings; Exhibits138: GE Healthcare Technologies Inc. - Overview; Exhibits139: GE Healthcare Technologies Inc. - Business segments; Exhibits140: GE Healthcare Technologies Inc. - Key news; Exhibits141: GE Healthcare Technologies Inc. - Key offerings; Exhibits142: GE Healthcare Technologies Inc. - Segment focus; Exhibits143: IBA Radiopharma Solutions - Overview; Exhibits144: IBA Radiopharma Solutions - Business segments; Exhibits145: IBA Radiopharma Solutions - Key news; Exhibits146: IBA Radiopharma Solutions - Key offerings; Exhibits147: IBA Radiopharma Solutions - Segment focus; Exhibits148: Jubilant Pharmova Ltd. - Overview; Exhibits149: Jubilant Pharmova Ltd. - Business segments; Exhibits150: Jubilant Pharmova Ltd. - Key news; Exhibits151: Jubilant Pharmova Ltd. - Key offerings; Exhibits152: Jubilant Pharmova Ltd. - Segment focus; Exhibits153: Koninklijke Philips N.V. - Overview; Exhibits154: Koninklijke Philips N.V. - Business segments; Exhibits155: Koninklijke Philips N.V. - Key news; Exhibits156: Koninklijke Philips N.V. - Key offerings; Exhibits157: Koninklijke Philips N.V. - Segment focus; Exhibits158: Mallinckrodt Plc - Overview; Exhibits159: Mallinckrodt Plc - Business segments; Exhibits160: Mallinckrodt Plc - Key news; Exhibits161: Mallinckrodt Plc - Key offerings; Exhibits162: Mallinckrodt Plc - Segment focus; Exhibits163: Medi-Radiopharma - Overview; Exhibits164: Medi-Radiopharma - Product / Service; Exhibits165: Medi-Radiopharma - Key offerings; Exhibits166: Necsa - Overview; Exhibits167: Necsa - Product / Service; Exhibits168: Necsa - Key offerings; Exhibits169: Novartis AG - Overview; Exhibits170: Novartis AG - Business segments; Exhibits171: Novartis AG - Key news; Exhibits172: Novartis AG - Key offerings; Exhibits173: Novartis AG - Segment focus; Exhibits174: Siemens Healthineers AG - Overview; Exhibits175: Siemens Healthineers AG - Business segments; Exhibits176: Siemens Healthineers AG - Key news; Exhibits177: Siemens Healthineers AG - Key offerings; Exhibits178: Siemens Healthineers AG - Segment focus; Exhibits179: Sirtex Medical Pty Ltd. - Overview; Exhibits180: Sirtex Medical Pty Ltd. - Product / Service; Exhibits181: Sirtex Medical Pty Ltd. - Key offerings; Exhibits182: Inclusions checklist; Exhibits183: Exclusions checklist; Exhibits184: Currency conversion rates for US$; Exhibits185: Research methodology; Exhibits186: Information sources; Exhibits187: Data validation; Exhibits188: Validation techniques employed for market sizing; Exhibits189: Data synthesis; Exhibits190: 360 degree market analysis; Exhibits191: List of abbreviations